Compare StocksEXPD vs PFE

Expeditors International of Washington, Inc. (EXPD) vs Pfizer, Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-08-03, EXPD is overvalued at $168, with a DCF intrinsic value of $103 and a margin of safety of -63%. PFE is undervalued at $25, with an intrinsic value of $127985960274 and a margin of safety of 100%. Of the two, PFE has the wider margin of safety.

EXPD
Expeditors International of Washington, Inc.
$167.89
VS
PFE
Pfizer, Inc.
$25.01

Rewards

EXPD
  • Expeditors International of Washington, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Return on equity has consistently exceeded 20% over 4 years, indicating efficient use of shareholder capital.
  • Share count has been reduced by 13% over the past 4 years through buybacks, increasing each share's claim on earnings.
PFE
  • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Trailing P/E of 19.1x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.

Risks

EXPD
  • Gross margin of 13.6% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • Trailing P/E of 27.1x is 32% above the historical average of 20.5x — the stock trades at a premium to its own history.
  • PEG ratio of 3.86 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • PEG ratio of 2.94 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 1.38 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.

Key Valuation Metrics

Learn more →
EXPD
PFE
Valuation
$783.25M
Free Cash Flow
$12.38B
3.57%
FCF Yield
N/A
27.08
Trailing P/E
19.09
23.90
Forward P/E
8.85
Quality & Moat
32.83%
ROIC
10.19%
36.64%
ROE
8.31%
13.62%
Gross Margin
74.80%
3.86
PEG Ratio
2.94
Balance Sheet Safety
Net cash
Net Debt / Equity
0.57
N/A
Interest Coverage
N/A
-0.66
Net Debt / EBITDA
2.03
0.96%
Dividend Yield
6.88%
EXPD: 4Ties: 1PFE: 6
EXPDPFE

Historical Fundamentals

Learn more →
EXPD

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
EXPD
$2.22
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$1.76B
Δ Market Cap
+$3.91B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-26.34
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
EXPD
62.6% Overvalued
Price is 62.6% above estimated fair value
Current Price: $167.89
Fair Value: $103.27
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PFE
100.0% Margin of Safety
Price is 100.0% below estimated fair value
Current Price: $25.01
Fair Value: $127985960274.09
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
EXPD

What growth rate is the market pricing in at $168?

+11.3%
Market-Implied Owner Earnings Growth
Standard FCF implies +11.8%

The market implies +11.3% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +11.8%, reflecting heavy growth investment.

PFE

What growth rate is the market pricing in at $25?

-14.2%
Market-Implied Owner Earnings Growth
Standard FCF implies -15.0%

The market implies -14.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding -15.0%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
EXPD
69/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with margin stability as the key competitive advantage. Improving revenue predictability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
EXPD
-2.55
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
EXPD
Insiders 0.6%Institutions 101.0%
No. of Institutional Holders1,310
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PFE
Insiders 0.1%Institutions 69.5%Retail & Other 30.4%
No. of Institutional Holders3,661
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
EXPD
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
PFE
0
Buys (3M)
0
Buys (12M)
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
EXPD
0
Sells (3M)
8
Sells (12M)
Total value (12M): $6.40M
WALL DANIEL R.
Chief Executive Officer
$884,927
@ $145.07 · 2026-02-27
BELL BLAKE R
Officer
$1.49M
@ $144.08 · 2026-02-27
EMMERT MARK A
Director
$730,350
@ $135.25 · 2025-11-07
DICKERMAN JEFFREY F
General Counsel
$201,255
@ $134.17 · 2025-11-05
CARLILE ROBERT PAUL
Director
$301,268
@ $120.51 · 2025-09-05
EMMERT MARK A
Director
$497,150
@ $121.26 · 2025-08-19
DICKERMAN JEFFREY F
General Counsel
$173,535
@ $118.05 · 2025-08-07
BELL BLAKE R
Officer
$2.12M
@ $117.89 · 2025-08-06
WALL DANIEL R.
Chief Executive Officer
$1.16M
@ $115.91 · 2025-05-12
DICKERMAN JEFFREY F
General Counsel
$146,923
@ $117.54 · 2025-02-20
CARLILE ROBERT PAUL
Director
$363,332
@ $121.11 · 2024-12-10
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PFE
1
Sells (3M)
1
Sells (12M)
Total value (12M): $51,400
DAMICO JENNIFER B.
Officer
$51,400
@ $25.70 · 2026-06-09
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
DAMICO JENNIFER B.
Officer
$147,714
@ $28.66 · 2024-08-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
EXPD
FearGreed
😐Neutral(55/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PFE
FearGreed
😐Neutral(52/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
EXPD
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (55)
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (52)
View EXPD Full AnalysisView PFE Full Analysis

Frequently Asked Questions: EXPD vs PFE

Is Expeditors International of Washington, Inc. or Pfizer, Inc. more undervalued in 2026?

Based on our discounted cash flow model, PFE trades at a 100.0% margin of safety (intrinsic value $127985960274 vs. price $25), compared to EXPD's -62.6% margin of safety (intrinsic $103 vs. $168).

Which stock has a wider economic moat, Expeditors International of Washington, Inc. or Pfizer, Inc.?

EXPD scores 69/100 (Narrow moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Pfizer, Inc. in financial distress?

PFE's Altman Z-Score of 1.4 places it in the Distress zone, signaling elevated bankruptcy risk. EXPD scores 8.8 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, Expeditors International of Washington, Inc. or Pfizer, Inc.?

EXPD earns 32.8% ROIC versus PFE's 10.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Expeditors International of Washington, Inc.'s or Pfizer, Inc.'s?

EXPD's dividend earns a safety score of 94/100 (Very Safe), compared to PFE's 24/100 (Unsafe). EXPD has raised its dividend for 3 consecutive years.

EXPD vs PFE: Which Is the Better Buy in 2026? | SafetyMargin.io